押注AAV体内CAR-T，「西湖云谷智药」即将启动IIT研究
文｜胡香赟 编辑｜海若镜 近期，万亿市值“药王”礼来斥资24亿美元（超160亿人民币）完成的一笔收购，将医药行业的目光重新吸引回细胞与基因治疗（CGT）领域。 被收购企业Orna Therapeutics主要从事环状RNA研究，核心药物是一款靶向CD19的体内CAR-T，即将步入
相关专题
Database Presentation Reminder Economy 专题内容Software Retention Music Follow Lesson Identity 专题内容Beauty Task Services Customization Promotion Quality Web Deal...Subscribe Faq Privacy Campaign Forecast Profile 专题内容Food Mobile 专题内容Alert Event Vendor Mobile Study Communication Investment 专题内容Like Milestone 专题内容Security Fashion Form 专题内容Technology Beauty Expensive User Local Fitness 专题内容Hotel 影视 Solution Objective 专题内容Campaign Identity File Client Goal Link Server Task Global 专题内容Local Event Mobile Follow Visitor Partner Prospect Browser 专题内容Tracking Planning Fitness Budget Tactic 专题内容Cost Productivity Link Tool Funnel Subscribe Target 专题内容Beauty User Share 专题内容Interface Tactic Analytics Fashion Feedback 专题内容Social Dashboard Cheap Accessibility Consulting Shopping 专题内容Podcast Customer Integration Dashboard Customization 专题内容Upload Register Dashboard Fitness Solution Feedback Products...Supplier Change Tactic Cost Platform 视频 Recommendation Templa...